Smruthi Organics [SMRUTHIORG] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Smruthi Organics Ltd. wins in 8 metrics, Divi's Laboratories Ltd. wins in 12 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Smruthi Organics Ltd. | Divi's Laboratories Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.60 | 67.11 | Smruthi Organics Ltd. |
| Price-to-Book Ratio | 1.91 | 10.82 | Smruthi Organics Ltd. |
| Debt-to-Equity Ratio | 13.16 | 0.58 | Divi's Laboratories Ltd. |
| PEG Ratio | -5.46 | 4.63 | Divi's Laboratories Ltd. |
| EV/EBITDA | 10.49 | 48.63 | Smruthi Organics Ltd. |
| Profit Margin (TTM) | 4.14% | 24.04% | Divi's Laboratories Ltd. |
| Operating Margin (TTM) | 10.45% | 29.65% | Divi's Laboratories Ltd. |
| EBITDA Margin (TTM) | 10.45% | 29.65% | Divi's Laboratories Ltd. |
| Return on Equity | 4.97% | 14.64% | Divi's Laboratories Ltd. |
| Return on Assets (TTM) | 3.19% | 12.94% | Divi's Laboratories Ltd. |
| Free Cash Flow (TTM) | $-15.39M | $2.15B | Divi's Laboratories Ltd. |
| Dividend Yield | 2.45% | 0.91% | Smruthi Organics Ltd. |
| 1-Year Return | -4.34% | 0.83% | Divi's Laboratories Ltd. |
| Price-to-Sales Ratio (TTM) | 1.22 | 16.18 | Smruthi Organics Ltd. |
| Enterprise Value | $1.39B | $1,635.46B | Divi's Laboratories Ltd. |
| EV/Revenue Ratio | 1.25 | 15.86 | Smruthi Organics Ltd. |
| Gross Profit Margin (TTM) | 70.32% | 63.71% | Smruthi Organics Ltd. |
| Revenue per Share (TTM) | $97 | $388 | Divi's Laboratories Ltd. |
| Earnings per Share (Diluted) | $4.01 | $93.66 | Divi's Laboratories Ltd. |
| Beta (Stock Volatility) | -0.24 | 0.19 | Smruthi Organics Ltd. |
Smruthi Organics Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Smruthi Organics Ltd. | 0.85% | -3.64% | 2.54% | -5.82% | -3.21% | 2.19% |
| Divi's Laboratories Ltd. | 0.40% | -0.66% | -0.42% | 4.06% | 2.31% | 4.40% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Smruthi Organics Ltd. | -4.34% | -14.68% | -52.59% | -2.06% | -9.72% | 74.81% |
| Divi's Laboratories Ltd. | 0.83% | 89.86% | 56.44% | 484.44% | 1,625.50% | 9,907.51% |
Performance & Financial Health Analysis: Smruthi Organics Ltd. vs Divi's Laboratories Ltd.
| Metric | SMRUTHIORG | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.36B | ₹1.69T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 3,593 | 253,443 |
| 90 Day Avg. Volume | 4,109 | 283,911 |
| Last Close | ₹119.00 | ₹6,623.00 |
| 52 Week Range | ₹95.00 - ₹164.00 | ₹5,636.50 - ₹7,071.50 |
| % from 52W High | -27.44% | -6.34% |
| All-Time High | ₹419.35 (Jul 12, 2021) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -71.62% | -6.34% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.29% | 0.12% |
| Quarterly Earnings Growth | -0.06% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.24% |
| Operating Margin (TTM) | 0.10% | 0.30% |
| Return on Equity (TTM) | 0.05% | 0.15% |
| Debt to Equity (MRQ) | 13.16 | 0.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹61.99 | ₹580.95 |
| Cash per Share (MRQ) | ₹1.04 | ₹122.95 |
| Operating Cash Flow (TTM) | ₹195.06M | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹35.63M | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.45% | 0.91% |
| Last 12-Month Dividend | ₹3.00 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Smruthi Organics Ltd. vs Divi's Laboratories Ltd.
| Metric | SMRUTHIORG (Apr 24, 2026) | DIVISLAB (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.60 | 67.11 |
| Forward P/E | N/A | 53.75 |
| PEG Ratio | -5.46 | 4.63 |
| Price to Sales (TTM) | 1.22 | 16.18 |
| Price to Book (MRQ) | 1.91 | 10.82 |
| Market Capitalization | ||
| Market Capitalization | ₹1.36B | ₹1.69T |
| Enterprise Value | ₹1.39B | ₹1.64T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.25 | 15.86 |
| Enterprise to EBITDA | 10.49 | 48.63 |
| Risk & Other Metrics | ||
| Beta | -0.24 | 0.19 |
| Book Value per Share (MRQ) | ₹61.99 | ₹580.95 |
Financial Statements Comparison: Smruthi Organics Ltd. vs Divi's Laboratories Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SMRUTHIORG (2025) | DIVISLAB (2025) |
|---|---|---|
| Revenue/Sales | 1.25B | 93.25B |
| Cost of Goods Sold | 709.72M | 38.70B |
| COGS % of Revenue | 56.9% | 41.5% |
| Gross Profit | 537.81M | 54.55B |
| Gross Margin | 43.1% | 58.5% |
| Research & Development | 9.24M | 270.00M |
| Operating Income (EBIT) | 66.81M | 25.71B |
| Operating Margin | 5.4% | 27.6% |
| EBITDA | 118.84M | 33.19B |
| EBITDA Margin | 9.5% | 35.6% |
| Pre-Tax Income | 49.00M | 29.16B |
| Pre-Tax Income % of Revenue | 3.9% | 31.3% |
| Income Tax | 13.37M | 7.25B |
| Income Tax % of Revenue | 1.1% | 7.8% |
| Net Income (Profit) | 35.63M | 21.91B |
| Profit Margin | 2.9% | 23.5% |
Balance Sheet & Liquidity Metrics
| Metric | SMRUTHIORG (2025) | DIVISLAB (2025) |
|---|---|---|
| Cash & Equivalents | 4.36M | 4.15B |
| Total Current Assets | 633.33M | 100.81B |
| Total Current Assets % of Revenue | 50.8% | 108.1% |
| Total Current Liabilities | 310.76M | 14.52B |
| Total Current Liabilities % of Revenue | 24.9% | 15.6% |
| Long-Term Debt | 81.62M | 20.00M |
| Long-Term Debt % of Revenue | 6.5% | 0.0% |
| Total Shareholders Equity | 716.29M | 149.69B |
| Retained Earnings | 583.25M | 134.00B |
| Retained Earnings % of Revenue | 46.8% | 143.7% |
| Property, Plant & Equipment | 110.00M | 3.19B |
Cash Flow Statement Comparison
| Metric | SMRUTHIORG (2025) | DIVISLAB (2025) |
|---|---|---|
| Operating Cash Flow | 195.06M | 19.67B |
| Operating Cash Flow % of Revenue | 15.6% | 21.1% |
| Capital Expenditures | -115.15M | -14.38B |
| Free Cash Flow | -15.39M | 2.15B |
| FCF Margin | -1.2% | 2.3% |
| Debt Repayment | -16.83M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SMRUTHIORG | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 11.45M | 265.47M |
| Float Shares | 3.82M | 117.72M |
| % Held by Insiders | 66.91% | 52.04% |
| % Held by Institutions | 0.00% | 28.65% |
| % Held by Public | 33.09% | 19.31% |
Dividend Analysis & Yield Comparison: Smruthi Organics Ltd. vs Divi's Laboratories Ltd.
| Metric | SMRUTHIORG | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | ₹3.00 | ₹60.00 |
| Last 12-Month Dividend Yield | 2.45% | 0.91% |
| 3-Year Avg Annual Dividend | ₹3.33 | ₹50.00 |
| 3-Year Avg Dividend Yield | 1.43% | 0.70% |
| 3-Year Total Dividends | ₹10.00 | ₹150.00 |
| Ex-Dividend Date | Jun 13, 2025 | Jul 25, 2025 |